首页 › 基金 › B Group, Inc. › PALI
B Group, Inc. 对 PALI 的持仓历史
PALISADE BIO INC · 医疗保健
B Group, Inc. 在 Q2 2026 的 13F 申报中披露持有 PALI(PALISADE BIO INC)11,414,285 股,市值约 US$23.9M,约占其申报组合的 11.20%,在其申报持仓中市值排名第 3 位。 B Group, Inc. 最近 3 个申报季度中有 3 个季度披露了 PALI 持仓,最早可追溯至 Q4 2025。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
B Group, Inc. 对 PALI 的持仓演变
B Group, Inc. 于 Q4 2025 首次披露 PALI 持仓:4,500,000 股(约 US$10.6M)。 该持仓在 Q2 2026 达到峰值 11,414,285 股,市值约 US$23.9M。 在 3 次申报中,B Group, Inc. 1 次增持、0 次减持、1 次保持不变。 最近一期申报(Q2 2026)显示持股 11,414,285 股、市值约 US$23.9M。 持仓曾出现大幅变动:Q1 2026 增持约 154% (随后一个季度股价上涨 19%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2025 | 4.50M | $10.57M | 新进 |
| Q1 2026 | 11.41M | $19.97M | 增持 |
| Q2 2026 | 11.41M | $23.86M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 PALI 与 13F 数据
PALI(PALISADE BIO INC)属于医疗保健行业。我们追踪的基金中还有 113 只申报持有 PALI,申报仓位最大的包括:Soleus Capital Management, L.P. (US$27.3M), Octagon Capital Advisors LP (US$21.5M), Boxer Capital Management, LLC (US$10.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 PALI 的基金
- Soleus Capital Management, L.P. 13.06M 股 · $27.30M · Q2 2026
- Octagon Capital Advisors LP 10.28M 股 · $21.48M · Q2 2026
- Boxer Capital Management, LLC 4.80M 股 · $10.03M · Q2 2026
- Squadron Capital Management LLC 3.00M 股 · $6.27M · Q2 2026
- Propel Bio Management, LLC 2.58M 股 · $5.40M · Q2 2026
- GREAT POINT PARTNERS LLC 2.28M 股 · $4.78M · Q2 2026
- SPHERA FUNDS MANAGEMENT LTD. 2.26M 股 · $4.72M · Q2 2026
- HighVista Strategies LLC 2.03M 股 · $4.24M · Q2 2026
- Artia Global Partners LP 1.99M 股 · $4.16M · Q2 2026
- PLATINUM INVESTMENT MANAGEMENT LTD 1.73M 股 · $3.62M · Q2 2026
- Ally Bridge Group (NY) LLC 1.23M 股 · $2.57M · Q2 2026
- Creek Drive Management Group LLC 440.00K 股 · $919.60K · Q2 2026
更多关于 B Group, Inc.
常见问题
How long has B Group, Inc. held PALI?
B Group, Inc. has disclosed PALI holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is B Group, Inc.'s current position in PALI?
As of Q2 2026, B Group, Inc. holds 11.41M shares of PALI (PALISADE BIO INC), valued at $23.86M, representing 11.20% of its reported portfolio and ranking #3.
Has B Group, Inc. been buying or selling PALI?
In the latest 13F filing (Q2 2026), B Group, Inc. held unchanged its position in PALI. The position peaked in Q2 2026 at 11.41M shares.
Which other funds hold PALI?
Other major institutional holders of PALI include Soleus Capital Management, L.P., Octagon Capital Advisors LP, Boxer Capital Management, LLC, among 113 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.